Stiefel Laboratories Reaps First Fruits of Barrier Therapeutics, Inc. (BTRX) Acquisition With Completion of Pivotal Phase III Clinical Trial for 200 mg Hyphanox(TM) (Itraconazole) Tablet
6/2/2009 11:26:44 AM
More...
|
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics, Inc. (BTRX)
8/6/2008 5:08:01 PM
More...
|
Stiefel Laboratories Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc. (BTRX)
8/5/2008 11:06:45 AM
More...
|
Stiefel Laboratories Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc. (BTRX)
8/5/2008 9:42:18 AM
More...
|
Stiefel Laboratories Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc. (BTRX)
7/29/2008 9:28:15 AM
More...
|
Barrier Therapeutics, Inc. (BTRX) Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
7/28/2008 9:33:11 AM
More...
|
Stiefel Laboratories Commences Tender Offer to Acquire Barrier Therapeutics, Inc. (BTRX)
7/8/2008 8:33:21 AM
More...
|
Barrier Therapeutics, Inc. (BTRX) and Stiefel Laboratories Sign Definitive Merger Agreement
6/23/2008 7:11:52 AM
More...
|
Barrier Therapeutics, Inc. (BTRX) Announces First Quarter 2008 Financial Results
4/30/2008 11:10:19 AM
More...
|
Barrier Therapeutics, Inc. (BTRX) to Present At the Deutsche Bank (DB) 33rd Annual Health Care Conference
4/28/2008 10:11:33 AM
More...
|
|